Popular on Amzeal
- FCTI, Inc. Announces John Grosheim as New Director of Security - 128
- Appeals Court Reverses Judge and Rules Against ACS - 124
- G. ENTERTAINMENT proudly presents Indianapolis' Inaugural Juneteenth Celebration Weekend Kick-Off with the "What the Funk" Concert
- New Bill Opens the Door for Lawsuits Against the Government Based on Contaminated Drinking Water at Camp Lejeune
- What Is an Endodontist? Do I Need A Root Canal?
- WWO Welcomes New Board And Staff Members
- Cpics' "The Next Gen Filmmaker Project" Announces Inaugural Mentee Class for Program Elevating South Asian Creatives
- Football is Serious Business for California High School Standout James "Bo" Thomas III
- EmpireXclusive Has a Big Weekend Ahead with ABIS Awards Gala and B.Simone Beauty Pop Up
- CHRIS JASPER "Raises The Bar" with the June Release of his New Music!
Similar on Amzeal
- L-Tron Team to Attend the National District Attorneys Association Summer Summit in Denver
- Doral Chamber of Commerce Proudly Welcomes BroadMAX Networks as a Trustee
- ITsavvy Approved to Sell Apple to Higher Education
- iTech offers 60-days free trial on expEDIum Medical Billing® product
- The Data Economics Company announces partnership with Incradia to release the ReVerse franchise on Lydion-based Game Development Platform
- Completion of funding round brings Metaphysiks one step closer to embodying the Metaverse
- Onlive Server Offer Hong Kong Cloud VPS Server Hosting with KVM Hypervisor Solution and Dedicated IP
- Local MD Resident Mike "C-Roc" Ciorrocco Accepted Into Exclusive Project 10K
- The Coming Era of Data as Code: Sean Scott Demonstrated a New Approach in Software at SPOUG22
- L-Tron granted patent for OSCR360 spherical imaging technology
CPC Scientific Announces New California Peptide API Manufacturing Facility
Amzeal News/10482150
SAN JOSE, Calif. - Amzeal -- CPC Scientific Inc., a leading global peptide CRDMO (Contract Research, Development, and Manufacturing Organization) has invested in a new peptide API (Active Pharmaceutical Ingredient) manufacturing site, bringing many new jobs to Rocklin, California. The 41,000 sq ft facility located at 3880 Atherton Rd, Rocklin, CA 95765 will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity and will diversify CPC Scientific's supply chain.
"CPC Scientific is entering an exciting period of growth and innovation for peptide and oligonucleotide therapeutic development and manufacturing, and we will continue to provide therapeutic APIs to pharmaceutical and biotech companies around the world. We are very pleased to partner with the City of Rocklin, California to bring manufacturing and Life-Science jobs to local American workers," said Shawn Lee, Ph.D., CEO.
Expanding CPC Scientific's manufacturing footprint in North America enables them to continue to produce innovative peptide products while providing additional capacity to specialty peptide APIs more rapidly.
More on Amzeal News
Peptide-based therapeutic candidates have been the fastest growing sector among all the chemical synthesized NCEs (New Chemical Entities) for new drug development in recent years. For over two decades, CPC Scientific has been a reliable partner for its clients all over the world including multinational pharmaceutical companies, biotech companies, and academic institutions by providing value-added one-stop-shop development and manufacturing services to support their clinical trials. CPC Scientific has been successfully supplying commercialized APIs to their clients in the U.S., Europe, Australia, Japan, and China for their peptide-based drugs and medical devices. By expanding their GMP manufacturing footprint, the CRDMO will enable their clients and partners to have multiple geographic options to ensure a secure API supply chain.
"We have helped many of our clients to bring an innovative drug into the market from a concept. With the new Rocklin site, we believe we will be able to contribute more especially to the Northern American market and we will continue making our efforts with our decades of peptide synthesis expertise to help our clients to save lives and improve human health worldwide," said Shawn Lee, Ph.D.
More on Amzeal News
The new Rocklin CGMP facility is scheduled to be online and fully operational by 2023. With manufacturing operations in Hangzhou (CN) and Rocklin, CA (US), these facilities will enable CPC Scientific to help meet the growing worldwide demand for peptide-based therapeutics and diagnostics.
About CPC Scientific.
Founded in 2001, CPC Scientific is a globally recognized and leading CRDMO specializing in synthetic peptide production, which is also expanding its footprint in synthetic oligonucleotides. The company works directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. CPC Scientific has the capability of serving customers from early drug discovery stages through clinical trials to commercial manufacturing and is proudly supplying commercial APIs to our partners all over the world. Dozens of isolated process and purification suites for peptide manufacturing enable simultaneous multi-Kg batch size projects. With an emphasis on technology, innovation, and experience, we are proud to have facilities inspected by many government agencies including U.S. Food and Drug Administration (FDA).
"CPC Scientific is entering an exciting period of growth and innovation for peptide and oligonucleotide therapeutic development and manufacturing, and we will continue to provide therapeutic APIs to pharmaceutical and biotech companies around the world. We are very pleased to partner with the City of Rocklin, California to bring manufacturing and Life-Science jobs to local American workers," said Shawn Lee, Ph.D., CEO.
Expanding CPC Scientific's manufacturing footprint in North America enables them to continue to produce innovative peptide products while providing additional capacity to specialty peptide APIs more rapidly.
More on Amzeal News
- Children's Shoe Brand joins Soles4Souls in Ukrainian Refugee Relief Efforts
- iTech offers 60-days free trial on expEDIum Medical Billing® product
- The Data Economics Company announces partnership with Incradia to release the ReVerse franchise on Lydion-based Game Development Platform
- Completion of funding round brings Metaphysiks one step closer to embodying the Metaverse
- Onlive Server Offer Hong Kong Cloud VPS Server Hosting with KVM Hypervisor Solution and Dedicated IP
Peptide-based therapeutic candidates have been the fastest growing sector among all the chemical synthesized NCEs (New Chemical Entities) for new drug development in recent years. For over two decades, CPC Scientific has been a reliable partner for its clients all over the world including multinational pharmaceutical companies, biotech companies, and academic institutions by providing value-added one-stop-shop development and manufacturing services to support their clinical trials. CPC Scientific has been successfully supplying commercialized APIs to their clients in the U.S., Europe, Australia, Japan, and China for their peptide-based drugs and medical devices. By expanding their GMP manufacturing footprint, the CRDMO will enable their clients and partners to have multiple geographic options to ensure a secure API supply chain.
"We have helped many of our clients to bring an innovative drug into the market from a concept. With the new Rocklin site, we believe we will be able to contribute more especially to the Northern American market and we will continue making our efforts with our decades of peptide synthesis expertise to help our clients to save lives and improve human health worldwide," said Shawn Lee, Ph.D.
More on Amzeal News
- On Anniversary of Surfside Tragedy, New Book Coaches Residents to Identify Warning Signs
- IceHouse Portable AC Review: 2022 Best Air Cooler For Room
- Local MD Resident Mike "C-Roc" Ciorrocco Accepted Into Exclusive Project 10K
- The Coming Era of Data as Code: Sean Scott Demonstrated a New Approach in Software at SPOUG22
- L-Tron granted patent for OSCR360 spherical imaging technology
The new Rocklin CGMP facility is scheduled to be online and fully operational by 2023. With manufacturing operations in Hangzhou (CN) and Rocklin, CA (US), these facilities will enable CPC Scientific to help meet the growing worldwide demand for peptide-based therapeutics and diagnostics.
About CPC Scientific.
Founded in 2001, CPC Scientific is a globally recognized and leading CRDMO specializing in synthetic peptide production, which is also expanding its footprint in synthetic oligonucleotides. The company works directly with leaders in the biotechnology and pharmaceutical industries to help bring life-changing therapeutics and diagnostics to market. CPC Scientific has the capability of serving customers from early drug discovery stages through clinical trials to commercial manufacturing and is proudly supplying commercial APIs to our partners all over the world. Dozens of isolated process and purification suites for peptide manufacturing enable simultaneous multi-Kg batch size projects. With an emphasis on technology, innovation, and experience, we are proud to have facilities inspected by many government agencies including U.S. Food and Drug Administration (FDA).
Source: CPC Scientific Inc.
0 Comments
Latest on Amzeal News
- London based AI start up Permutable announces partnership with US based ESG Enterprise
- Martine Dowden Gives a Presentation for the Southwest Valley .NET User Group
- Calgary-based Orthodontics Provider Opens New Location
- Entrinsik Promotes Robin Lamb to Vice President of Client Services
- Announcing The Christina Hepburn Breast Cancer Support Campaign
- Patent Lawyer Finder: a Free, AI-Powered Tool to Help Inventors Find Experienced Patent Lawyers
- Altavoz Distribution Launches Regina Belle Records
- Robinson honored again by both Rolls-Royce and The Fabricator for excellence
- CompuData Ranked on Channel Futures 2022 MSP 501 – Tech Industry's Most Prestigious List of MSPs
- Same Day Windshields has a Florida location near you
- Abendroth Fortel Offers Financial Support to Develop Agricultural Products Supply Chains
- Barcoding, Inc. Becomes a GS1 US Solution Partner
- Keep Black Love Alive --Spelman Women's Research and Resource Center and chromatic black™ Sponsor Well-Being Advocacy Forum
- THine V-by-One® HS Technology Used in NVIDIA G-SYNC® Processor
- ITI Systems Announces Opening of Los Angeles Office
- Console & Associates: The Passing of the Camp Lejeune Act Puts Justice Within Reach
- Today!Mecha Infinity And Neuto House PH Signed A Charity Partnership Contract
- New Study Projects Mobile AR Revenue to Reach $36.26 Billion by 2026
- New 4.3" IPS TFT Displays Available at Newhaven Display
- Sionic Launches 'Pay-By-Bank' Real-Time Payment (RTP) Service For U.S. Merchants